Actively Recruiting
HIV Treatment Adherence Dose Determination Trial
Led by University of Connecticut · Updated on 2025-08-29
400
Participants Needed
2
Research Sites
325 weeks
Total Duration
On this page
Sponsors
U
University of Connecticut
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy and implementation of behavioral interventions designed to improve durable viral suppression.
CONDITIONS
Official Title
HIV Treatment Adherence Dose Determination Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed HIV positive
- Confirmed prescribed antiretroviral therapy
- Confirmed non-adherent to anti-retroviral therapy
You will not qualify if you...
- Does not have access to a phone
- Does not have access to the internet
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University of Connecticut
Storrs, Connecticut, United States, 06269
Actively Recruiting
2
University of Connecticut Field Site
Atlanta, Georgia, United States, 30308
Actively Recruiting
Research Team
S
Seth Kalichman, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here